ArticleOncogene2026
Histone methyltransferase KMT2D promotes castration-resistant prostate cancer progression by reactivating AR through FOXA1.
Mayao Luo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it